Amended And Restated Distribution Agreement Sample Contracts

Mplx Lp – Third Amended and Restated Distribution Agreement (March 13th, 2018)
Medicines Company (The) – Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Triple Asterisks Denote Omissions NINTH AMENDMENT TO SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENT (March 1st, 2018)

This Ninth Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, LLC, f/k/a Integrated Commercialization Solutions, Inc., a California limited liability company with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of October 3, 2017 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

United Dominion Realty L P – Third Amended and Restated Distribution Agreement (April 27th, 2017)

Reference is made to the Third Amended and Restated Distribution Agreement, dated September 1, 2011 (the "Agreement"), by and among UDR, Inc. (the "Company") and United Dominion Realty, L.P. (the "Operating Partnership") and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as amended by Amendment No. 1 thereto, dated July 29, 2014, by and among the Company, the Operating Partnership and Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (collectively, the "Parties"). On April 27, 2017, the Company and the Operating Partnership filed with the Securities and Exchange Commission (the "Commission") an "automatic shelf registration statement" as defined under Rule 405 under the Securities Act of 1933, as amended (the "1933 Act

4th Amendment to Amended and Restated Distribution Agreement (April 26th, 2017)

THIS 4TH AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (this Fourth Amendment) is made and effective this 1st Day of April, 2017 (the Fourth Amendment Effective Date), by and among Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822, (Accredo), United Therapeutics Corporation, a Delaware corporation, having offices at 1040 Spring Street, Silver Spring, Maryland (UT), and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (SD). SD and Accredo are collectively referred to herein as the Distributor.

Second Amendment to Amended and Restated Distribution Agreement (REMODULIN(r)) (February 22nd, 2017)

THIS SECOND AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (this Second Amendment) is made and effective November 1, 2016 (the Second Amendment Effective Date) by and among, United Therapeutics Corporation, a Delaware corporation having offices at 1040 Spring Street, Silver Spring, Maryland (UT), Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822 (Accredo), and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (SD). SD and Accredo are collectively referred to herein as the Distributor.

3rd Amendment to Amended and Restated Distribution Agreement (February 22nd, 2017)

THIS 3RD AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (this Third Amendment) is made and effective this 27th Day of December, 2016 (the Third Amendment Effective Date), by and among Accredo Health Group, Inc., a Delaware corporation having offices at 6272 Lee Vista Boulevard, Orlando FL, 32822, (Accredo), United Therapeutics Corporation, a Delaware corporation, having offices at 1040 Spring Street, Silver Spring, Maryland (UT), and Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation with offices at 255 Technology Park, Lake Mary, Florida, 32746 (SD). SD and Accredo are collectively referred to herein as the Distributor.

Amended and Restated Distribution Agreement (August 31st, 2016)

THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT (this "Agreement"), made as of this 30th day of August, 2016 to be effective as of the 16th of July, 2016 (the "Effective Date"), is by and between Hard Rock Solutions, LLC, a Utah limited liability company, whose address is 1583 East, 1700 South, Vernal, Utah 84078 ("Supplier"), and Drilling Tools International, Inc., a Louisiana Corporation, whose address is 3701 Briarpark Dr., Suite 150, Houston, TX 77042 ("Distributor") (Supplier and Distributor being sometimes hereinafter referred to individually as a "Party" and collectively as the "Parties").

Mplx Lp – Second Amended and Restated Distribution Agreement (August 4th, 2016)
Bioventus Inc. – Amended and Restated Distribution Agreement by and Between Bioventus Llc and Seikagaku Corporation Dated as of June 30, 2016 (July 19th, 2016)

This Amended and Restated Distribution Agreement (the Agreement), dated as of June 30, 2016 (the Effective Date), by and between BIOVENTUS LLC, a Delaware limited liability company having its principal place of business at 4721 Emperor Boulevard, Durham, NC 27703 (Distributor) and SEIKAGAKU CORPORATION, a Japanese corporation having its principal place of business at Marunouchi Center Building, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005, Japan (Company) amends and restates, in its entirety, the Amended and Restated Exclusive Distribution Agreement (the A&R Exclusive Distribution Agreement), in effect as of May 4, 2012, by and between Distributor and Company. Distributor and Company are sometimes referred to herein individually as a Party and collectively as the Parties.

3M COMPANY Medium-Term Notes, Series F Second Amended and Restated Distribution Agreement (May 19th, 2016)

3M Company, a Delaware corporation (the Company), proposes to issue and sell from time to time its Medium-Term Notes, Series F (the Securities) in an aggregate amount up to $18,000,000,000 and agrees with each of you (individually, an Agent, and collectively, the Agents) as set forth in this Second Amended and Restated Distribution Agreement (this Agreement). An aggregate principal amount of $8,204,156,000 of Securities were issued prior to the date of this Agreement and are currently outstanding.

Medicines Company (The) – Seventh Amendment to Second Amended and Restated Distribution Agreement (May 5th, 2015)

This Seventh Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of March 5, 2015 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

New Laser Corp – Amended and Restated Distribution Agreement (April 21st, 2015)

This AMENDED AND RESTATED DISTRIBUTION AGREEMENT (the Agreement) is entered into as of March 18, 2015 (the Effective Date) between MONSTER ENERGY COMPANY, a Delaware corporation (formerly known as Hansen Beverage Company) (MEC), and COCA-COLA REFRESHMENTS USA, INC., a Delaware corporation (formerly known as Coca-Cola Enterprises, Inc.) (Distributor). MEC and Distributor are referred to herein collectively as the parties and individually as a party hereto. This Agreement amends and restates in its entirety that certain Monster Energy Distribution Agreement between MEC and Distributor as of October 3, 2008 (the Original Agreement). MEC and Distributor are referred to herein collectively as the parties and individually as a party hereto.

Fourth Amended and Restated Distribution Agreement (February 25th, 2015)
Amended and Restated Distribution Agreement (November 6th, 2014)

This Amended and Restated Distribution Agreement (Agreement), is made and entered into as of August 13, 2014 (the Effective Date), by and between Sprouts Farmers Market, Inc. (SFM), a Delaware corporation, and Natures Best (NB), a California corporation.

Third Amended and Restated Distribution Agreement (July 31st, 2014)

Reference is made to the Third Amended and Restated Distribution Agreement, dated September 1, 2011 (the "Agreement"), by and among UDR, Inc. (the "Company") and United Dominion Realty, L.P. (the "Operating Partnership") and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (collectively, the "Parties"). On July 29, 2014, the Company and the Operating Partnership filed with the Securities and Exchange Commission (the "Commission") an "automatic shelf registration statement" as defined under Rule 405 under the Securities Act of 1933, as amended (the "1933 Act"), on Form S-3 (File No. 333-197710) (the "Registration Statement"), in respect of certain of the Company's and the Operating Partnership's securities, in anticipation of the expiration of the Company's automatic shelf registration statement on Form S-3 (File No. 333-176616) (the "Exp

United Dominion Realty L P – Third Amended and Restated Distribution Agreement (July 31st, 2014)

Reference is made to the Third Amended and Restated Distribution Agreement, dated September 1, 2011 (the "Agreement"), by and among UDR, Inc. (the "Company") and United Dominion Realty, L.P. (the "Operating Partnership") and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC (collectively, the "Parties"). On July 29, 2014, the Company and the Operating Partnership filed with the Securities and Exchange Commission (the "Commission") an "automatic shelf registration statement" as defined under Rule 405 under the Securities Act of 1933, as amended (the "1933 Act"), on Form S-3 (File No. 333-197710) (the "Registration Statement"), in respect of certain of the Company's and the Operating Partnership's securities, in anticipation of the expiration of the Company's automatic shelf registration statement on Form S-3 (File No. 333-176616) (the "Exp

Second Amendment to Amended and Restated Distribution Agreement (July 1st, 2014)

THIS SECOND AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (the "Amendment") is made as of this 27th day of June, 2014, by and between KAPPA PUBLISHING GROUP, INC., a Delaware corporation, whose place of business is at 6198 Butler Pike, Blue Bell, Pennsylvania 19422 (hereafter referred to as "Publisher") and KABLE DISTRIBUTION SERVICES, INC., a Delaware corporation, whose place of business is at Suite 4C, 14 Wall Street, New York, NY 10005 (hereafter referred to as 'Distributor").

Medicines Company (The) – Sixth Amendment to Second Amended and Restated Distribution Agreement (May 12th, 2014)

This Sixth Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of February 01, 2014 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

Mid-America Apartments, L.P. – Amended and Restated Distribution Agreement (November 19th, 2013)
Mid-America Apartments, L.P. – Amended and Restated Distribution Agreement (November 19th, 2013)
Mid-America Apartments, L.P. – Amended and Restated Distribution Agreement (November 19th, 2013)
Mid-America Apartments, L.P. – Amended and Restated Distribution Agreement (November 19th, 2013)
BGS Acquisition Subsidiary, Inc. – Amended and Restated Distribution Agreement (November 15th, 2013)

* The prices in Schedule 3.1 will apply to all Samples of 3P and Internal Volume submitted to Transnetyx during a quarter based on the average weekly volume of Samples of 3P and Internal Volume, respectively, submitted during the last eight (8) weeks of the prior quarter.

Medicines Company (The) – Fourth Amendment to Second Amended and Restated Distribution Agreement (November 5th, 2013)

This Fourth Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of May 1st, 2013 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

Medicines Company (The) – Fifth Amendment to Second Amended and Restated Distribution Agreement (November 5th, 2013)

This Fifth Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of September 12, 2013 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

Third Amended and Restated Distribution Agreement (August 3rd, 2012)
Quebec – QUEBEC Medium-Term Notes, Series A, Due Nine Months or More From Date of Issue AMENDED AND RESTATED DISTRIBUTION AGREEMENT New York, New York (November 22nd, 2011)

Quebec wishes to amend and restate effective as of the date hereof that certain Distribution Agreement, dated July 29, 1994, as amended June 28, 1996, August 20, 1999, May 23, 2002, May 28, 2002, December 11, 2003, October 23, 2008 and June 15, 2011, among Quebec and certain of you, as Agents, and confirms its agreement with you as Agents with respect to the issue and sale by Quebec of its Medium-Term Notes, Series A, Due Nine Months or More from Date of Issue registered under the Registration Statements referred to in the third paragraph of the introduction to this Agreement (the Notes). The Notes are to be issued under the fiscal agency agreement dated as of May 30, 2002, as may be amended or supplemented from time to time (the Fiscal Agency Agreement, which term whenever used herein shall mean said fiscal agency agreement as the same shall have been amended from time to time) among Quebec and Citibank, N.A., as fiscal agent (the Fiscal Agent, which term shall, unless the context oth

Medicines Company (The) – Second Amendment to Second Amended and Restated Distribution Agreement (November 9th, 2011)

This Second Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 ("Distributor"). This Amendment is effective as of September 1, 2011 (the "Amendment Effective Date"). MDCO and Distributor shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties".

Medicines Company (The) – First Amendment to Second Amended and Restated Distribution Agreement (November 9th, 2011)

This First Amendment to Second Amended and Restated Distribution Agreement (this "Amendment") is between The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 (the "Distributor"). This Amendment is effective as of July 1, 2011 (the "Amendment Effective Date").

First Amendment to Amended and Restated Distribution Agreement (July 21st, 2011)

THIS FIRST AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (the "Amendment") is made as of this 14th day of February, 2011, by and between KAPPA PUBLISHING GROUP, INC., a Delaware corporation, whose place of business is at 6198 Butler Pike, Blue Bell, Pennsylvania 19422 (hereafter referred to as "Publisher") and KABLE DISTRIBUTION SERVICES, INC., a Delaware corporation, whose place of business is at Suite 4C, 14 Wall Street, New York, NY 10005 (hereafter referred to as "Distributor").

Medicines Company (The) – Second Amended and Restated Distribution Agreement (May 24th, 2011)

This Second Amended and Restated Distribution Agreement (together with its schedules and exhibits, the "Agreement") is entered into by The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 ("MDCO"), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 (the "Distributor"), effective as of October 1, 2010 (the "Effective Date").

Medicines Company (The) – Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. SECOND AMENDED AND RESTATED DISTRIBUTION AGREEMENT (March 15th, 2011)

This Second Amended and Restated Distribution Agreement (together with its schedules and exhibits, the Agreement) is entered into by The Medicines Company, a Delaware corporation with offices at 8 Sylvan Way, Parsippany, NJ 07054 (MDCO), and Integrated Commercialization Solutions, Inc., a California corporation with offices at 3101 Gaylord Parkway, Frisco, TX 75034 (the Distributor), effective as of October 1, 2010 (the Effective Date).

Amended and Restated Distribution Agreement (February 24th, 2011)

THIS AMENDED AND RESTATED DISTRIBUTION AGREEMENT (Agreement) is made as of February 21, 2011 (the Effective Date), by and between United Therapeutics Corporation (UT), a Delaware corporation, with offices at 1040 Spring Street, Silver Spring, Maryland and Accredo Health Group, Inc. (DISTRIBUTOR), a Delaware corporation, with offices at 1640 Century Center Parkway, Memphis, Tennessee 38134.

EQUITY DISTRIBUTION PROGRAM Amended and Restated Distribution Agreement (February 9th, 2011)

Rentech, Inc., a Colorado corporation (the Company), confirms its agreement with Knight Capital Americas, L.P, successor in interest to Knight Capital Markets LLC, as agent (you or KCA), to amend and restate the Distribution Agreement dated February 2, 2010 (the Original Distribution Agreement) as provided herein with respect to the issuance and sale from time to time by the Company, in the manner and subject to the terms and conditions described below, of up to an aggregate number of shares of common stock, $0.01 par value per share (the Common Stock), of the Company having a aggregate gross sales price of up to $50,000,000 (the Maximum Number of Shares), including for the avoidance of doubt, the shares of Common Stock issued and sold pursuant to the Original Distribution Agreement. Such shares are hereinafter collectively referred to as the Shares. The Shares are described in the Prospectus referred to below.

Addendum to Amended and Restated Distribution Agreement (November 10th, 2010)

This ADDENDUM TO AMENDED AND RESTATED DISTRIBUTION AGREEMENT (this Addendum), is made effective and entered into as of November 5, 2010 (the Effective Date), by and among Novadaq Technologies Inc., a Canadian corporation (Novadaq Parent), Novadaq Corp., a Delaware corporation (Novadaq), which is a wholly owned subsidiary of Novadaq Parent, PLC Systems Inc., a Yukon Territory corporation (PLC Parent), and PLC Medical Systems, Inc., a Delaware corporation (PLC), which is a wholly owned subsidiary of PLC Parent.